β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione tre
Author: ["Liam R Brunham","Janine K Kruit","Terry D Pape","Jenelle M Timmins","Anne Q Reuwer","Zainisha Vasanji","Brad J Marsh","Brian Rodrigues","James D Johnson","John S Parks","C Bruce Verchere","Michael R Hayden"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Type 2 diabetes is characterized by both peripheral insulin resistance and reduced insulin secretion by β-cells. The reasons for β-cell dysfunction in this disease are incompletely understood but may include the accumulation of toxic lipids within this cell type. We examined the role of Abca1, a cellular cholesterol transporter, in cholesterol homeostasis and insulin secretion in β-cells. Mice with specific inactivation of Abca1 in β-cells had markedly impaired glucose tolerance and defective insulin secretion but normal insulin sensitivity. Islets isolated from these mice showed altered cholesterol homeostasis and impaired insulin secretion in vitro. We found that rosiglitazone, an activator of the peroxisome proliferator–activated receptor-γ, which upregulates Abca1 in β-cells, requires β-cell Abca1 for its beneficial effects on glucose tolerance. These experiments establish a new role for Abca1 in β-cell cholesterol homeostasis and insulin secretion, and suggest that cholesterol accumulation may contribute to β-cell dysfunction in type 2 diabetes.
Cite this article
Brunham, L., Kruit, J., Pape, T. et al. β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 13, 340–347 (2007). https://doi.org/10.1038/nm1546
